Favogli MV 1mg/500mg/0.2mg Tablet
Marketer
Faveo Pharmaceuticals
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Favogli MV 1mg/500mg/0.2mg Tablet
Diabetic patients utilizing Favogli MV 1mg/500mg/0.2mg tablets, classified as an anti-diabetic combination medication, should adhere to prescribed dosages for effective type 2 diabetes management in adults. Administer this medication with food, consistently at the same time daily, for optimal glycemic control. Dosage adjustments, determined by your physician based on blood glucose monitoring, may be necessary. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight control as directed by your healthcare provider. Lifestyle modifications are integral to successful diabetes management. Hypoglycemia (low blood sugar), manifesting as sweating, dizziness, headache, or trembling, is a prevalent side effect. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, edema, blurred vision, bone fractures, upper respiratory infections, and weight gain. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Pre-existing heart conditions, pregnancy, or breastfeeding necessitate prior physician consultation. Regular blood glucose checks and potentially blood tests to monitor blood cell counts and liver function are recommended under your doctor's care.
Uses of Favogli MV 1mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Favogli MV 1mg/500mg/0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Favogli MV 1mg/500mg/0.2mg Tablet on an empty stomach.
Common Side effects of Favogli MV 1mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Favogli MV 1mg/500mg/0.2mg Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Favogli MV 1mg/500mg/0.2mg Tablet on an empty stomach.
How Favogli MV 1mg/500mg/0.2mg Tablet works:
Each Favogli MV tablet (1mg/500mg/0.2mg) contains a triple-action blend of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Favogli MV 1mg/500mg/0.2mg Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Favogli MV 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against any risks before prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Favogli MV 1mg/500mg/0.2mg Tablet while breastfeeding is likely unsafe. Preliminary evidence from human studies indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
Patients with kidney disease should likely avoid Favogli MV 1mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice is recommended. The use of Favogli MV 1mg/500mg/0.2mg Tablets is discouraged in individuals with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Favogli MV 1mg/500mg/0.2mg Tablets cautiously, as dosage modification may be necessary. Individuals with mild to moderate liver disease typically begin with a reduced Favogli MV 1mg/500mg/0.2mg Tablet dose; however, its use is contraindicated in those with severe hepatic dysfunction. Medical advice is recommended.
What if you forget to take Favogli MV 1mg/500mg/0.2mg Tablet :
Should you forget to take your Favogli MV 1mg/500mg/0.2mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Favogli MV 1mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |
3,018 People bought this recently
